Charcot-Marie-Tooth Disease Clinical Trial
Official title:
The Impact of Charcot-Marie-Tooth Disease in the Real World
An observational, non-interventional registry study to collect real-world data from people living with Charcot-Marie-Tooth disease (CMT) and its treatment, which will be available to researchers to further the knowledge of Charcot-Marie-Tooth disease and improve patient care.
The registry uses Vitaccess' digital real-world evidence platform and has been developed in collaboration with CMT experts, Patient Advocacy Organizations (PAOs) and the biopharmaceutical company Pharnext. Eligible participants install a study app on their smartphone. Researchers access aggregated, anonymised data via a cloud-based research portal. The platform provides benefits to participants, which it is hoped will encourage persistence with data submission; these include options to download a copy of their symptom diary, a clinically-validated Knowledge feature, and access to high-level results from the study data. The aggregated data are available in close to real time via "dashboards" and can be analysed according to a number of pre-set criteria (e.g. disease stage, age, geographic location). State-of-the-art technologies and security policies are used in the platform to ensure industry-standard data storage and privacy for all users. Participants' personally identifiable information will remain confidential at all times, and researchers will not be able to identify individuals. The study is ethics-approved in all scope countries and led by a Scientific Advisory Board comprising representatives from international PAOs, patients and key opinion leaders from each country, and study leads from both Pharnext Société Anonyme (SA) and Vitaccess Ltd. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06203093 -
Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking
|
||
Recruiting |
NCT02979145 -
Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
|
N/A | |
Terminated |
NCT03254199 -
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
|
Phase 2 | |
Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
Completed |
NCT00149045 -
Follow up and Observation of Charcot Marie Tooth Disease in Families
|
N/A | |
Completed |
NCT04786522 -
Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease
|
||
Recruiting |
NCT05011006 -
NT-3 Levels and Function in Individuals With CMT
|
||
Recruiting |
NCT05902351 -
Natural History Study for Charcot Marie Tooth Disease
|
||
Terminated |
NCT03943290 -
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
|
Phase 2 | |
Active, not recruiting |
NCT04762758 -
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
|
Phase 3 | |
Completed |
NCT02788734 -
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
|
N/A | |
Recruiting |
NCT02532244 -
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
|
||
Terminated |
NCT05827419 -
Hearing and Balance Disorders in Peripheral Neuropathy
|
||
Terminated |
NCT03124459 -
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
|
Phase 2 | |
Terminated |
NCT03810508 -
A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)
|
||
Recruiting |
NCT04010188 -
A Registered Cohort Study on Charcot-Marie-Tooth Disease
|
||
Completed |
NCT00271635 -
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
|
Phase 2 | |
Completed |
NCT03715283 -
Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care
|
N/A | |
Completed |
NCT02001038 -
Survey of Current Management of Orthopaedic Complications in CMT Patients
|
N/A | |
Not yet recruiting |
NCT01289704 -
Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
|
Phase 2/Phase 3 |